Filter Results:
(10)
Show Results For
- All HBS Web
(50)
- Faculty Publications (10)
Show Results For
- All HBS Web
(50)
- Faculty Publications (10)
Iceland →
Page 1 of 10
Results
- August 2018 (Revised February 2019)
- Case
Alvogen: Scaling Entrepreneurship
By: Daniel Isenberg, William R. Kerr and Alexis Brownell
Keywords: Pharmaceutical Companies; Scaling; Generic Drugs; Entrepreneurship; Leadership; Pharmaceutical Industry; Asia; Europe; United States; Iceland
Isenberg, Daniel, William R. Kerr, and Alexis Brownell. "Alvogen: Scaling Entrepreneurship." Harvard Business School Case 819-038, August 2018. (Revised February 2019.)
- October 2016 (Revised February 2017)
- Teaching Note
Alvogen
By: Daniel Isenberg, William R. Kerr and Alexis Brownell
Alvogen is an Icelandic pharmaceutical company that makes and sells generic drugs. Founder and CEO Robert Wessman is deciding whether to take on private equity investors willing to buy out all shareholders, merge with a large and publicly-traded US pharmaceutical... View Details
- 28 Apr 2016
- Other Presentation
Unlocking the Potential of Geothermal Energy: Strategic Implications for Iceland, Other Nations and the International Community
By: Michael E. Porter and Christian H.M. Ketels
Professor Porter initiated the mapping of Iceland Geothermal Cluster Initiative in cooperation with the consulting company Gekon. He and his colleaque Dr. Christian Ketels introduced their findings in November 2010 at the first Iceland Geothermal Conference held in... View Details
Keywords: Iceland; Geothermal; Renewable; Competitiveness; Competition; Renewable Energy; Energy Industry; Iceland
Porter, Michael E., and Christian H.M. Ketels. "Unlocking the Potential of Geothermal Energy: Strategic Implications for Iceland, Other Nations and the International Community." Iceland Geothermal Conference, Reykjavik, Iceland, April 28, 2016.
- February 2016 (Revised February 2017)
- Case
Alvogen
By: Daniel Isenberg and William Kerr
Alvogen is a young Icelandic generic pharmaceutical company, whose CEO believes that his global strategy will give them an edge in this competitive industry.
Robert Wessman, Alvogen’s CEO, was also previously the CEO of Actavis, another Icelandic generics... View Details
Robert Wessman, Alvogen’s CEO, was also previously the CEO of Actavis, another Icelandic generics... View Details
Keywords: Pharmaceutical Companies; Generic Drugs; Entrepreneurship; Globalization; Risk and Uncertainty; Pharmaceutical Industry; Iceland
Isenberg, Daniel, and William Kerr. "Alvogen." Harvard Business School Case 816-064, February 2016. (Revised February 2017.)
- 1 Nov 2012
- Other Presentation
Profile of the Icelandic Geothermal Cluster
By: Michael E. Porter and Christian H.M. Ketels
Profile of the Icelandic Geothermal Cluster View Details
Porter, Michael E., and Christian H.M. Ketels. "Profile of the Icelandic Geothermal Cluster." Institute for Strategy and Competitiveness, Reykjavik, Iceland, November 1, 2012.
- 1 Nov 2010
- Other Presentation
The Icelandic Geothermal Cluster: Enhancing Competitiveness and Creating a new Engine of Icelandic Growth
Presentation on competitiveness and clusters View Details
Porter, Michael E. "The Icelandic Geothermal Cluster: Enhancing Competitiveness and Creating a new Engine of Icelandic Growth." Institute for Strategy and Competitiveness, Reykjavik, Iceland, November 1, 2010.
- 1 Nov 2010
- Other Presentation
Value-Based Health Care Delivery
This presentation draws on Redefining Health Care: Creating Value-Based Competition on Results (with Elizabeth O. Teisberg), Harvard Business School Press, May 2006; "A Strategy for Health Care Reform—Toward a Value-Based System," New England Journal of... View Details
Porter, Michael E. "Value-Based Health Care Delivery." Arion Bank, Reykjavik, Iceland, November 1, 2010.
- November 2007 (Revised August 2009)
- Case
Iceland: Small fish in a global pond
By: Michael E. Porter and Christian H.M. Ketels
Describes the economic development of Iceland since 1945, focusing in particular on the years since 2000, when Iceland experienced strong growth and Icelandic companies aggressively internationalized. View Details
Porter, Michael E., and Christian H.M. Ketels. "Iceland: Small fish in a global pond." Harvard Business School Case 708-472, November 2007. (Revised August 2009.)
- 2 Oct 2006
- Other Presentation
Building A Competitive Economy: Implications for Iceland
Competitiveness presentation delivered in Reykjavik, Iceland. View Details
Porter, Michael E. "Building A Competitive Economy: Implications for Iceland." Institute for Strategy and Competitiveness, Reykjavik, Iceland, October 2, 2006.
- February 2006 (Revised August 2006)
- Case
deCODE Genetics: Hunting for Genes to Develop Drugs
By: Debora L. Spar
In 1996, Kari Stefansson launched a new kind of biotechnology company and a whole new way of attacking diseases. Based in Iceland, his firm, deCODE Genetics, plans to identify the individual genetic markers that lead to society's most prevalent diseases. To do so, it... View Details
Keywords: Information; Innovation Strategy; Genetics; Ethics; Health Disorders; Biotechnology Industry; Iceland
Spar, Debora L., and Chris Bebenek. "deCODE Genetics: Hunting for Genes to Develop Drugs." Harvard Business School Case 706-040, February 2006. (Revised August 2006.)